[SGYP] Synergy Pharmaceuticals, Inc.
Overview
Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization:
Exchange: NASDAQ
The data is delayed by 15 minutes.
Strongest Trends Summary For SGYP
SGYP is in the long-term down -100% below S&P in 3 years.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders, as well as is in Phase IIb clinical trials for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company also develops SP-333, which is in Phase II clinical trials to treat GI inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
See how to gain 20% in 14 sec with TrendsInvesting
Fundamental Ratios
| Shares Outstanding | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | ||||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | Sales Growth - Q/Q | P/E | ||||
| P/E To EPS Growth | P/S | P/BV | Price/Cash Per Share | ||||
| Price/Free Cash Flow | ROA | -54.85% | ROE | 432.02% | ROI | ||
| Current Ratio | 9.53 | Quick Ratio | Long Term Debt/Equity | 1.23 | Debt Ratio | -0.77 | |
| Gross Margin | Operating Margin | Net Profit Margin | Dividend Payout Ratio | ||||
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | 5.41 M | Cash From Investing Activities | -50.01 M | Cash From Operating Activities | -23.15 M | Gross Profit | |
| Net Profit | -27.39 M | Operating Profit | -22.8 M | Total Assets | 194.83 M | Total Current Assets | 182.28 M |
| Total Current Liabilities | 19.13 M | Total Debt | 200 M | Total Liabilities | 219.57 M | Total Revenue |
Technical Data
| High 52 week | 2.23 | Low 52 week | 0.07 | Last close | 0.24 | Last change | -17.21% |
| RSI | 42.37 | Average true range | 0.03 | Beta | 0.79 | Volume | 31.45 M |
| Simple moving average 20 days | -22.7% | Simple moving average 50 days | -1.08% | Simple moving average 200 days | -79.06% |
Performance Data
| Performance Week | -22.62% | Performance Month | -36.75% | Performance Quart | -37.23% | Performance Half | -87.69% |
| Performance Year | -87.09% | Performance Year-to-date | 110.8% | Volatility daily | 9.36% | Volatility weekly | 20.93% |
| Volatility monthly | 42.89% | Volatility yearly | 148.57% | Relative Volume | 577.63% | Average Volume | 13.41 M |
| New High | New Low |
News
2019-04-12 15:00:00 | FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD
2019-04-12 10:19:00 | FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC - UXIN, SGYP & MHLD
2019-04-11 16:45:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-04-09 20:06:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-04-09 10:24:00 | SGYP & MHLD - Class Action Bronstein, Gewirtz & Grossman, LLC
2019-04-07 09:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-04-05 10:23:00 | Class Action Bronstein, Gewirtz & Grossman, LLC - SGYP & MHLD
2019-04-04 15:10:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-04-03 10:22:00 | Class Action Reminder Bronstein, Gewirtz & Grossman, LLC - SGYP & MHLD
2019-04-02 15:35:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-03-29 15:00:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD
2019-03-29 10:57:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Reminder - UXIN, SGYP & MHLD
2019-03-28 14:27:31 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-03-28 10:57:00 | Bronstein, Gewirtz & Grossman, LLC Class Action Update - UXIN, SGYP & MHLD
2019-03-26 16:15:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP
2019-03-21 15:00:00 | INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceuticals, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-21 10:08:00 | INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-19 19:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-03-19 11:08:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-15 10:02:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Deadline: April 12, 2019
2019-03-14 21:14:50 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
2019-03-12 16:57:33 | [$$] Synergy Pharma Bankruptcy Plan Cleared for Creditor Poll
2019-03-11 15:00:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Plaintiff Deadline: April 12, 2019
2019-03-11 10:01:00 | SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Synergy Pharmaceutical, Inc. SGYP and Lead Plaintiff Deadline: April 12, 2019
2019-03-07 20:47:59 | Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Synergy Pharmaceuticals, Inc. – SGYP
2019-03-06 09:00:00 | Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
2019-03-05 08:04:11 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-03-04 14:12:13 | Chester County to lose 137 pharma jobs
2019-03-01 18:30:00 | Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
2019-02-28 16:24:43 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-27 08:13:48 | The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings
2019-02-26 18:04:00 | Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
2019-02-26 18:00:00 | Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets
2019-02-26 17:25:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-25 12:35:45 | [$$] Puerto Rico's Debt Saga May Land Back in Washington's Lap
2019-02-22 17:48:17 | [$$] Synergy Pharmaceuticals Wins Approval for Bankruptcy Loan
2019-02-20 18:15:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-20 17:11:00 | Investor Alert: Kaplan Fox Announces Investigation Of Synergy Pharmaceuticals Inc.
2019-02-20 17:08:49 | Bausch Health Companies Inc BHC Q4 2018 Earnings Conference Call Transcript
2019-02-13 15:22:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
2019-02-13 11:41:57 | [$$] Firm Retention Summary: Synergy Pharmaceuticals Inc.
2019-02-12 11:28:45 | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Synergy Pharmaceuticals Inc. SGYP
2019-01-29 08:04:59 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
2019-01-25 08:00:00 | Small Cap Stocks Breaking Out